Department of Neurology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, PR China; School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Preclinical in vitro and transgenic mouse study of a novel nanoplatform without human data, efficacy metrics, or comparison to standard-of-care controls; demonstrates proof-of-concept but requires clinical translation.
Preclinical study demonstrating in vitro efficacy and early-stage animal model results with a novel nanotherapeutic, but lacking human trials, controlled comparators, or quantified efficacy metrics.